D-dimer, Fibrinogen and their association with IL-17 as a Risk factor of Cardiovascular events in Psoriasis Patients
DOI:
https://doi.org/10.36320/ajb/v16.i3.17304Keywords:
D-dimer, Fibrinogen, IL-17, Psoriasis, thromboembolism, and CVD.Abstract
Abstract: Background: Psoriasis is an inflammation disease linked with the risk of venous thromboembolism (VTE), metabolic syndrome, and increased atherosclerotic arterial disease risk, especially in severe cases, The factors that are thought to contribute to VTE are hypercoagulability, endothelial injury and venous stasis. Objectives: The research attempts for searching into sensitivity as well as specificity of D-dimer and Fibrinogen and their relationships with IL-17 represents a heart disease hazards with moderately severe psoriasis.
Materials and Methods: This case-control study enrolled 50 male patients with psoriasis range aged 15 to 60 years, were matched by age and sex with 50 healthy controls, at Hospitals of the Morgan Teaching and Imam Sadiq in Babylon province, Iraq, between July to October of 2023. The psoriatic scores and levels of D-dimer, Fibrinogen and IL-17 in sera and psoriatic CVD complications were measured. Correlations and Methods of logistical regressing have been applied for these markers for predict within venous thrombotic events.
Results: Psoriasis patients had significantly higher levels of D-dimer, Fibrinogen as well as ILـ17 levels (p<0,01) more than controllingـgroup. A positive matrix correlation of these markers with PASI. Logistic regression analysis of psoriasis severity predicts with a higher significant OR of 2.636 (95% CI: 1.317 - 5.277) associated with CVD events compared to those without CVD. In addition to ROC analysis indicates a discriminatory capacity predicted for CVD events in psoriasis patients that D-dimer of AUC (95% CI): 0.901(0.818-0.984), and Fibrinogen was 0.888 (0.797-0.978), while, IL-17 was AUC (95% CI): 0.892 (0.799-0.985).
Conclusion: D-dimer and Fibrinogen along with higher IL-17 levels has been identified as a predict factors for greater danger of cardiovascular illnesses in individuals having moderately to severely severe psoriasis.
Downloads
References
- Criado, P. R., Antinori, L. C. L., Maruta, C. W., & Reis, V. M. S. D. (2013). Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis. Anais brasileiros de dermatologia, 88(3), 355-360. DOI: https://doi.org/10.1590/abd1806-4841.20131532
- Kamath, S., & Lip, G. Y. H. (2003). Fibrinogen: biochemistry, epidemiology and determinants. Qjm, 96(10), 711-729. DOI: https://doi.org/10.1093/qjmed/hcg129
- Hegazy, E. M., Ibrahim, H. M., Abd Elfatah, F. E., & Younis, A. M. (2023). Evaluation Of Neopterin Level And Disease Severity In Patients With Psoriasis Vulgaris Treated With Narrowband UVB. SVU-International Journal of Medical Sciences, 6(2), 81-87. DOI: https://doi.org/10.21608/svuijm.2023.183238.1480
- Kunz, M., Simon, J. C., & Saalbach, A. (2019). Psoriasis: obesity and fatty acids. Frontiers in immunology, 10, 1807. DOI: https://doi.org/10.3389/fimmu.2019.01807
- Fan, Z., Wang, L., Jiang, H., Lin, Y., & Wang, Z. (2021). Platelet dysfunction and its role in the pathogenesis of psoriasis. Dermatology, 237(1), 56-65. DOI: https://doi.org/10.1159/000505536
- Grän, F., Kerstan, A., Serfling, E., Goebeler, M., & Muhammad, K. (2020). Focus: skin: current developments in the immunology of psoriasis. The Yale journal of biology and medicine, 93(1), 97.
- Bishop M, Fody E and Schoeff, L (2000). Clinical Chemistry. principle and correlation: procedures. 10th ed., Lippincott Williams and Wilkins. Philadelphia; 180-220.
- Elobeid, H. E., Alfarouk, K. O., Ahmed, N., & Aljarbou, A. N. (2017). Correlation between the body mass index and psoriasis in dermatology and venereology teaching hospital in Khartoum. AJDV, 6(2), 30-9.
- Al-Saba, A. H., Shemran, K. A., & Al-Hattab, M. K. (2022). Study of serum chitinase-3-like-1 protein (CHI3L1) and C-reactive protein (CRP) in patients suffering from chronic plaque psoriasis. Medical Journal of Babylon, 19(4), 729-735. DOI: https://doi.org/10.4103/MJBL.MJBL_236_22
- Sullivan, L. M. (2022). Essentials of biostatistics for public health. Jones & Bartlett Learning.
- Atayoglu, A. T., Çapar, A. G., Basmisirlioglu, E., Yasar, Y., Aykemat, Y., Guner Atayoglu, A., & Inanc, N. (2022, November). Investigation of the Relationship between the Disease Severity and Quality of Life of Psoriasis Patients and Their Anthropometric Measurements and Diets. In Healthcare (Vol. 10, No. 11, p. 2323). MDPI. DOI: https://doi.org/10.3390/healthcare10112323
- Criado, R. F., Bensi, C. G., Criado, P. R., Henriques, M. T., de Espindola, B. A. R., & Machado Filho, C. D. A. (2021). Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center: a cross-sectional study. Anais Brasileiros de Dermatologia, 96(2), 148-154. DOI: https://doi.org/10.1016/j.abd.2020.07.006
- Zhao, L., Zeng, Y., Sun, L., Zhang, Z., Yang, K., Li, Z., ... & Yang, W. (2023). Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease. Journal of Inflammation Research, 4019-4030. DOI: https://doi.org/10.2147/JIR.S427992
- von Stebut, E., Boehncke, W. H., Ghoreschi, K., Gori, T., Kaya, Z., Thaci, D., & Schäffler, A. (2020). IL-17A in psoriasis and beyond: cardiovascular and metabolic implications. Frontiers in immunology, 10, 3096. DOI: https://doi.org/10.3389/fimmu.2019.03096
- Hillary, T., Clijmans, J., Vermeire, S., Lambert, J., Garmyn, M., Imbrechts, M., & Vanassche, T. (2021). Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis. Annals of Medicine, 53(1), 1076-1083. DOI: https://doi.org/10.1080/07853890.2021.1942974
- Prinz, I., Sandrock, I., & Mrowietz, U. (2020). Interleukin-17 cytokines: effectors and targets in psoriasis—a breakthrough in understanding and treatment. Journal of Experimental Medicine, 217(1). DOI: https://doi.org/10.1084/jem.20191397
- Cheng, L., Fu, Q., Zhou, L., Fan, Y., Liu, F., Fan, Y., ... & Wu, X. (2022). D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus. BMC Cardiovascular Disorders, 22(1), 82. DOI: https://doi.org/10.1186/s12872-022-02531-x
- Wang, B., Deng, H., Hu, Y., Han, L., Huang, Q., Fang, X., ... & Yan, K. (2022). The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio. Arthritis research & therapy, 24(1), 17. DOI: https://doi.org/10.1186/s13075-021-02715-4
- Arunadevi, D., Raghavan, V., & Nott, A. (2022). Comparative and correlative study of hematologic parameters and selective inflammatory biomarkers in psoriasis. International Journal of Nutrition, Pharmacology, Neurological Diseases, 12(1), 34-38. DOI: https://doi.org/10.4103/ijnpnd.ijnpnd_68_21
- Kutwin, M., Migdalska-Sęk, M., Brzeziańska-Lasota, E., Zelga, P., & Woźniacka, A. (2021). An analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R expression and their correlation with clinical course in patients with psoriasis. Journal of Clinical Medicine, 10(24), 5834. DOI: https://doi.org/10.3390/jcm10245834
- Liu, L., Cui, S., Liu, M., Huo, X., Zhang, G., & Wang, N. (2022). Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study. Frontiers in cardiovascular medicine, 9, 829709. DOI: https://doi.org/10.3389/fcvm.2022.829709
Downloads
Published
Issue
Section
License
Copyright (c) 2024 intisar .sharba, Shrooq ALsaleh
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
